semaglutide approval for weight loss The FDA has approved a new higher dose (7.2 mg) of Wegovy (semaglutide) injection, Wegovy HD, and long-term weight maintenance in certain adult patients—in just 54 days from filing FDA approves obesity drug that

With our expert team and the latest cutting-edge technologies, we've developed comprehensive wellness regimens so you can look and feel your best

Semaglutide has become a widely used medication for managing type 2 diabetes and obesity

DPP-4 inhibitors (gliptins such as sitagliptin or linagliptin) and GLP-1 receptor agonists (such as semaglutide, dulaglutide, or liraglutide) enhance glucose-dependent insulin secretion and are associated with low hypoglycaemia risk

Published by the iPharma Research Team Medically reviewed by PCCA- and NHIA-certified compounding pharmacists with 27+ years of clinical experience in sterile compounding, GLP-1 therapy, and personalized medicine Last reviewed July 2026 Educational information only

Its possible to see weight loss in the first month of treatment

clinical response depends on many factors including metabolism, dose tolerance, and lifestyle